Participated · Series A · Feb 2026

Vienna-based Nyra Health has built myReha, an MDR Class IIa-certified software platform that lets patients train speech, cognition, fine motor skills, and everyday abilities with real-time, AI-generated feedback. The product is already deployed in more than 100 neurological clinics and is integrated into the German Pension Insurance’s standard care program, giving automatic reimbursement through 28 statutory and private insurers and theoretical access to over 40 million insured individuals. Proprietary speech models and continuous data collection let the system adapt therapy intensity and content to each patient’s performance, and a randomized controlled trial has shown significantly greater cognitive and language improvements versus standard care. Clinicians use Nyra Insights to monitor progress and adjust programs, while an AI Content Studio dynamically creates individualized therapy exercises. With ISO 13485 and ISO 27001 certifications and eleven peer-reviewed publications, the company positions itself as a clinically validated, data-driven leader in digital neurorehabilitation. Nyra Health plans to deepen integration with additional DACH clinic groups, expand reimbursement schemes across Germany, Austria, and Switzerland, and prepare a U.S. launch in partnership with an international pharmaceutical company. A separate €4.2 million research project with U.S. universities is advancing its multimodal AI models for therapeutic interaction and diagnostics.